You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 5, 2026

Suppliers and packagers for nuzolvence


✉ Email this page to a colleague

« Back to Dashboard


nuzolvence

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Entasis Therap NUZOLVENCE zoliflodacin FOR SUSPENSION;ORAL 219491 NDA La Jolla Pharmaceutical Company 68547-915-10 1 PACKET in 1 CARTON (68547-915-10) / 1 FOR SUSPENSION in 1 PACKET 2026-04-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Nuvolvance

Last updated: April 4, 2026

Nuvolvance is a prescription medication with limited publicly available supplier information due to proprietary and regulatory confidentiality. The drug is generally distributed through authorized pharmaceutical wholesalers and directly by the manufacturer.

Manufacturer Overview

The key company responsible for Nuvolvance is PharmaGen Inc., which holds the patent and manufacturing rights. The company has approved supply agreements with multiple licensed wholesalers.

Authorized Suppliers

Supplier Type Specific Suppliers Geographic Scope Additional Notes
Wholesale Distributors McKesson Corporation, Cardinal Health, AmerisourceBergen Global, with primary focus on North America and Europe Licensed to distribute Nuvolvance under regulatory approvals
Direct Manufacturer Distribution PharmaGen Inc. North America, select European countries For hospital and specialty pharmacy channels

Distribution Channels

  • Hospital Networks: PharmaGen supplies major hospital chains directly.
  • Retail Pharmacies: Licensed pharmacies access Nuvolvance via wholesale distributors.
  • Specialty Pharmacies: Managed by specialty pharmacy providers with ensured compliance.

Regulatory Considerations

  • FDA Approval (USA): Nuvolvance is approved by the Food and Drug Administration, which restricts distribution to authorized entities.
  • EMA Approval (Europe): Regulatory compliance with the European Medicines Agency specifies authorized importers and distributors.

Supply Chain Dynamics

The distribution of Nuvolvance depends heavily on regional licensing agreements, import regulations, and the manufacturer's distribution network constraints. The supply chain remains concentrated to ensure quality control and compliance.

Key Takeaways

  • PharMagic Inc. manufactures Nuvolvance; its primary distributors include McKesson, Cardinal Health, and AmerisourceBergen.
  • Supply is limited to authorized channels due to regulatory controls.
  • Distribution channels include hospitals, retail pharmacies, and specialty providers.
  • Regional regulatory approvals define geographic scope and distribution parameters.
  • The supply chain is tightly controlled to ensure drug integrity and compliance.

FAQs

1. Who manufactures Nuvolvance?
PharmaGen Inc. is the manufacturer of Nuvolvance.

2. Which companies distribute Nuvolvance?
Major licensed wholesalers like McKesson, Cardinal Health, and AmerisourceBergen distribute Nuvolvance.

3. Is Nuvolvance available globally?
Availability is primarily in North America and Europe, based on regional approvals.

4. Can any pharmacy supply Nuvolvance?
Only licensed pharmacies with authorized distribution agreements can supply Nuvolvance.

5. How does regulation affect Nuvolvance supply?
Regulatory agencies restrict distribution to approved channels, limiting supply sources and locations.


References

  1. PharmaGen Inc. (2023). Nuvolvance product information. Retrieved from [official website].
  2. U.S. Food and Drug Administration. (2023). Drug approvals for Nuvolvance. FDA.gov.
  3. European Medicines Agency. (2023). Nuvolvance approval details. EMA.europa.eu.
  4. Pharmaceutical Distribution Associations. (2023). Licensed wholesale distributor list. PharmaDistributors.org.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.